vs

Side-by-side financial comparison of EAGLE MATERIALS INC (EXP) and Lantheus Holdings, Inc. (LNTH). Click either name above to swap in a different company.

EAGLE MATERIALS INC is the larger business by last-quarter revenue ($556.0M vs $406.8M, roughly 1.4× Lantheus Holdings, Inc.). EAGLE MATERIALS INC runs the higher net margin — 18.5% vs 13.3%, a 5.2% gap on every dollar of revenue. On growth, Lantheus Holdings, Inc. posted the faster year-over-year revenue change (4.0% vs -0.4%). Lantheus Holdings, Inc. produced more free cash flow last quarter ($81.4M vs $60.8M). Over the past eight quarters, EAGLE MATERIALS INC's revenue compounded faster (8.0% CAGR vs 4.9%).

Eagle Materials Inc. is an American producer of building materials based in Dallas, Texas. The company produces cement, concrete, construction aggregate, gypsum, wallboard, paperboard, and sand for hydraulic fracturing.

Lantheus Holdings, Inc. is a global healthcare firm specializing in the development, manufacturing and commercialization of innovative diagnostic imaging agents and related solutions. Its offerings cover core medical segments including oncology, cardiology and urology, with primary markets across North America and other key global regions.

EXP vs LNTH — Head-to-Head

Bigger by revenue
EXP
EXP
1.4× larger
EXP
$556.0M
$406.8M
LNTH
Growing faster (revenue YoY)
LNTH
LNTH
+4.4% gap
LNTH
4.0%
-0.4%
EXP
Higher net margin
EXP
EXP
5.2% more per $
EXP
18.5%
13.3%
LNTH
More free cash flow
LNTH
LNTH
$20.6M more FCF
LNTH
$81.4M
$60.8M
EXP
Faster 2-yr revenue CAGR
EXP
EXP
Annualised
EXP
8.0%
4.9%
LNTH

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
EXP
EXP
LNTH
LNTH
Revenue
$556.0M
$406.8M
Net Profit
$102.9M
$54.1M
Gross Margin
28.9%
59.2%
Operating Margin
19.0%
Net Margin
18.5%
13.3%
Revenue YoY
-0.4%
4.0%
Net Profit YoY
-13.9%
558.8%
EPS (diluted)
$3.22
$0.86

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EXP
EXP
LNTH
LNTH
Q4 25
$556.0M
$406.8M
Q3 25
$638.9M
$384.0M
Q2 25
$634.7M
$378.0M
Q1 25
$470.2M
$372.8M
Q4 24
$558.0M
$391.1M
Q3 24
$623.6M
$378.7M
Q2 24
$608.7M
$394.1M
Q1 24
$476.7M
$370.0M
Net Profit
EXP
EXP
LNTH
LNTH
Q4 25
$102.9M
$54.1M
Q3 25
$137.4M
$27.8M
Q2 25
$123.4M
$78.8M
Q1 25
$66.5M
$72.9M
Q4 24
$119.6M
$-11.8M
Q3 24
$143.5M
$131.1M
Q2 24
$133.8M
$62.1M
Q1 24
$77.1M
$131.1M
Gross Margin
EXP
EXP
LNTH
LNTH
Q4 25
28.9%
59.2%
Q3 25
31.3%
57.9%
Q2 25
29.2%
63.8%
Q1 25
22.2%
63.8%
Q4 24
31.9%
63.5%
Q3 24
32.7%
63.9%
Q2 24
30.7%
64.9%
Q1 24
25.1%
65.4%
Operating Margin
EXP
EXP
LNTH
LNTH
Q4 25
19.0%
Q3 25
11.4%
Q2 25
23.3%
Q1 25
27.4%
Q4 24
32.8%
29.1%
Q3 24
34.2%
35.3%
Q2 24
32.0%
26.1%
Q1 24
26.9%
28.8%
Net Margin
EXP
EXP
LNTH
LNTH
Q4 25
18.5%
13.3%
Q3 25
21.5%
7.2%
Q2 25
19.4%
20.8%
Q1 25
14.1%
19.6%
Q4 24
21.4%
-3.0%
Q3 24
23.0%
34.6%
Q2 24
22.0%
15.8%
Q1 24
16.2%
35.4%
EPS (diluted)
EXP
EXP
LNTH
LNTH
Q4 25
$3.22
$0.86
Q3 25
$4.23
$0.41
Q2 25
$3.76
$1.12
Q1 25
$2.01
$1.02
Q4 24
$3.56
$-0.18
Q3 24
$4.26
$1.79
Q2 24
$3.94
$0.88
Q1 24
$2.23
$1.87

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EXP
EXP
LNTH
LNTH
Cash + ST InvestmentsLiquidity on hand
$419.0M
$359.1M
Total DebtLower is stronger
$568.7M
Stockholders' EquityBook value
$1.5B
$1.1B
Total Assets
$3.8B
$2.2B
Debt / EquityLower = less leverage
0.52×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EXP
EXP
LNTH
LNTH
Q4 25
$419.0M
$359.1M
Q3 25
$35.0M
$382.0M
Q2 25
$59.7M
$695.6M
Q1 25
$20.4M
$938.5M
Q4 24
$31.2M
$912.8M
Q3 24
$93.9M
$866.4M
Q2 24
$46.5M
$757.0M
Q1 24
$34.9M
$718.3M
Total Debt
EXP
EXP
LNTH
LNTH
Q4 25
$568.7M
Q3 25
$567.9M
Q2 25
$566.8M
Q1 25
$1.2B
$566.1M
Q4 24
$565.3M
Q3 24
$613.0K
Q2 24
$563.2M
Q1 24
$1.1B
$562.5M
Stockholders' Equity
EXP
EXP
LNTH
LNTH
Q4 25
$1.5B
$1.1B
Q3 25
$1.5B
$1.1B
Q2 25
$1.5B
$1.2B
Q1 25
$1.5B
$1.2B
Q4 24
$1.5B
$1.1B
Q3 24
$1.4B
$1.2B
Q2 24
$1.4B
$1.0B
Q1 24
$1.3B
$945.5M
Total Assets
EXP
EXP
LNTH
LNTH
Q4 25
$3.8B
$2.2B
Q3 25
$3.4B
$2.3B
Q2 25
$3.4B
$2.1B
Q1 25
$3.3B
$2.1B
Q4 24
$3.0B
$2.0B
Q3 24
$3.1B
$2.0B
Q2 24
$3.0B
$1.9B
Q1 24
$2.9B
$1.8B
Debt / Equity
EXP
EXP
LNTH
LNTH
Q4 25
0.52×
Q3 25
0.51×
Q2 25
0.49×
Q1 25
0.86×
0.49×
Q4 24
0.52×
Q3 24
0.00×
Q2 24
0.55×
Q1 24
0.84×
0.59×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EXP
EXP
LNTH
LNTH
Operating Cash FlowLast quarter
$170.8M
$90.2M
Free Cash FlowOCF − Capex
$60.8M
$81.4M
FCF MarginFCF / Revenue
10.9%
20.0%
Capex IntensityCapex / Revenue
19.8%
2.2%
Cash ConversionOCF / Net Profit
1.66×
1.67×
TTM Free Cash FlowTrailing 4 quarters
$231.8M
$354.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EXP
EXP
LNTH
LNTH
Q4 25
$170.8M
$90.2M
Q3 25
$204.6M
$105.3M
Q2 25
$136.6M
$87.1M
Q1 25
$62.8M
$107.6M
Q4 24
$119.9M
$157.7M
Q3 24
$233.3M
$175.1M
Q2 24
$132.6M
$84.7M
Q1 24
$63.4M
$127.2M
Free Cash Flow
EXP
EXP
LNTH
LNTH
Q4 25
$60.8M
$81.4M
Q3 25
$96.1M
$94.7M
Q2 25
$60.5M
$79.1M
Q1 25
$14.5M
$98.8M
Q4 24
$72.5M
$141.4M
Q3 24
$166.8M
$159.3M
Q2 24
$99.5M
$73.5M
Q1 24
$30.9M
$119.0M
FCF Margin
EXP
EXP
LNTH
LNTH
Q4 25
10.9%
20.0%
Q3 25
15.0%
24.7%
Q2 25
9.5%
20.9%
Q1 25
3.1%
26.5%
Q4 24
13.0%
36.1%
Q3 24
26.7%
42.0%
Q2 24
16.3%
18.7%
Q1 24
6.5%
32.2%
Capex Intensity
EXP
EXP
LNTH
LNTH
Q4 25
19.8%
2.2%
Q3 25
17.0%
2.8%
Q2 25
12.0%
2.1%
Q1 25
10.3%
2.3%
Q4 24
8.5%
4.2%
Q3 24
10.7%
4.2%
Q2 24
5.4%
2.8%
Q1 24
6.8%
2.2%
Cash Conversion
EXP
EXP
LNTH
LNTH
Q4 25
1.66×
1.67×
Q3 25
1.49×
3.79×
Q2 25
1.11×
1.11×
Q1 25
0.94×
1.47×
Q4 24
1.00×
Q3 24
1.63×
1.34×
Q2 24
0.99×
1.36×
Q1 24
0.82×
0.97×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EXP
EXP

External Customers$283.5M51%
Gypsum Wallboard$175.9M32%
Recycled Paperboard$47.8M9%
Corporate Joint Venture$29.4M5%
Other$11.8M2%
Western Pennsylvania Acquisition$7.6M1%

LNTH
LNTH

Radiopharmaceutical Oncology$240.2M59%
Definity$85.3M21%
Strategic Partnerships And Other$23.3M6%
Techne Lite$21.0M5%
Licenseand Royalty Revenues$17.4M4%
Other$13.6M3%
Other Precision Diagnostics$5.9M1%

Related Comparisons